3Joseph H, Hulse, BiotecImologies : past history, present state and furore prospects[J] .Trends in Food Science & Technology, 2004, 15:3 - 18.
4Paul BB, Heather RE, Guthrie. Trends in ion channel drug discovery.:advances in screening teclmologies [J] .Trends in Biotechnology, 2003,21 : 563 - 569.
6Ruiwu Liu, Ching-Yi H, Kit SL. New approaches in identifying drags to inactivate oncogene products [J]. Scminars in Cancer Biology, 2004,14:13-21.
7Daniel IC. Protein Structure: Detennination, Analysis, and Applications for Drag Discovery[M]. New York, Marcel Dekker Inc, 2003. 606.
8Yanhuai Liu, Yanling Sun. China traditional Chinese Medicine (TCM)Patent Database[J]. World Patent Infomation, 2004, 26:91-96.
二级参考文献31
1Broach JR, Thorner J. High-throughput screening for drug discovery[J]. Nature,1996,384:14.
2Burbaum J. Miniaturization technologies in HTS: How fast, how small, how soon? Drug Discov Today,1998,3:313.
3Lin JH, Lu AYH. Role of pharmacokinetics and metabolism in drug discovery and development[J]. Pharmacol Rev,1997,49(7):403.
4Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by seven UK-owned pharmaceutical companies(1964-1985)[J]. Br J Clin Pharmacol,1998,25:387.
5Berman J, Halm K, Adkison KK, et al. Simultaneous pharmacokinetic screeing of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput[J]. Journal of Medicinal Chemistry,1997;40:827.
6Bayliss MK, Frick LW. High-throughput pharmacokinetics: cassette dosing[J]. Current Opinions in Drug Discovery and Development,1999,2:20.
7Bajpai M, Adkison KK. High-throughput screening for lead optimization: a rational approach. Current Opinions in Drug Discovery and Development,2000,3:63.
8Lee CP, Vrueh RLA, Smith PL. Selection of development candidates based on in vitro permeability measurements[J]. Advances in Drug Delivery Reviews,1997,23:47.
9Sinko PJ. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches[J]. Current Opinions in Drug Discovery and Development,1999,2:48.
10Chong S, Dando SA, Morrison RA. Evaluation of biocoat intestinal epithelium differentiation environment (3-day cultured Caco-2 cells) as an absorption screening model with improved productivity[J]. Pharm Research,1997,14:1835.
8John TK.Making virtual screening a reality[J].Pnas,2003,100(12):6902-6903.
9Reddy AS,Pati P,Kumar PP,et al.Virtual screening in drug discovery-a computational perspective[J].Current Protein and Peptide Science,2007,8(4):329-351.
